madopar
- CAS NO.:37270-69-2
- Empirical Formula: C10H15N3O5.C9H11NO4
- Molecular Weight: 454.433
- SAFETY DATA SHEET (SDS)
What is madopar?
Drug interactions
Potentially hazardous interactions with other drugs
Anaesthetics: risk of arrhythmias with volatile liquid
anaesthetics such as halothane
.
Antidepressants: hypertensive crisis with MAOIs
and linezolid (including moclobemide) - avoid for at
least 2 weeks after stopping MAOI.
Bupropion: increased risk of side effects of levodopa
Ferrous sulphate: reduces AUC of levodopa by
30-50%, clinically significant in some but not all
patients.
Metabolism
Levodopa is rapidly decarboxylated by the enzyme
aromatic l-amino acid decarboxylase, mostly in the gut,
liver, and kidney, to dopamine, which is metabolised
in turn, principally to dihydroxyphenylacetic acid
(DOPAC) and homovanillic acid (HVA). Other routes
of metabolism include O-methylation, transamination,
and oxidation, producing a variety of minor metabolites
including noradrenaline and 3-O-methyldopa; the latter
may accumulate in the CNS due to its relatively long
half-life.
About 80% of an oral dose of levodopa is excreted in the
urine within 24 hours, mainly as dihydroxyphenylacetic
and homovanillic acids. Only small amounts of levodopa
are excreted unchanged in the faeces.
Benserazide is rapidly excreted in the urine in the form
of metabolites, mostly within the first 6 hours; 85% of
urinary excretion occurrs within 12 hours. It is mainly
metabolised in the gut and appears to protect levodopa
against decarboxylation primarily in the gut, but alsoin the rest of the body, mainly by way of its metabolite
trihydroxybenzylhydrazine.
Safety information for madopar
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%View Details
99903-60-3 -
88491-46-7 98%View Details
88491-46-7 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
1784294-80-9 98%View Details
1784294-80-9 -
Lithium ClavulanateView Details
61177-44-4